Kodiak Sciences Inc
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
KOD$107.10+7.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31,2023 | December 31,2022 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $285,507 | $190,433 |
| Marketable securities | — | 288,500 |
| Prepaid expenses and other current assets | 3,802 | 7,072 |
| Total current assets | 289,309 | 486,005 |
| Restricted cash | 6,324 | 6,324 |
| Property and equipment, net | 120,482 | 56,384 |
| Operating lease right-of-use asset | 54,541 | 59,369 |
| Other assets | 8,716 | 58,546 |
| Total assets | $479,372 | $666,628 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $13,608 | $9,130 |
| Accrued and other current liabilities | 18,351 | 33,440 |
| Operating lease liability | 9,770 | 9,926 |
| Total current liabilities | 41,729 | 52,496 |
| Operating lease liability, net of current portion | 71,862 | 77,807 |
| Liability related to sale of future royalties | 100,000 | 99,996 |
| Other liabilities | — | 162 |
| Total liabilities | 213,591 | 230,461 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | — | — |
| Common stock, $0.0001 par value, 490,000,000 shares authorized at December 31, 2023 and December 31, 2022; 52,508,602 and 52,333,850 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 5 | 5 |
| Additional paid-in capital | 1,418,307 | 1,329,509 |
| Accumulated other comprehensive income (loss) | — | (1,307) |
| Accumulated deficit | (1,152,531) | (892,040) |
| Total stockholders’ equity | 265,781 | 436,167 |
| Total liabilities and stockholders’ equity | $479,372 | $666,628 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.